PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells

Recent studies have reported that aberrant PR domain zinc finger protein 14 (PRDM14) expression is associated with the therapeutic sensitivity of cancer cells to drugs. However, its role in lung adenocarcinoma (LUAD) remains unclear. The present study aimed to determine the functions of knockdown or...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Saifei, Ma, Xiaokun, Zheng, Ni, Wang, Guoyu, Wang, Menghan, Xia, Wei, Yu, Donghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789100/
https://www.ncbi.nlm.nih.gov/pubmed/33355367
http://dx.doi.org/10.3892/mmr.2020.11788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789100/
https://www.ncbi.nlm.nih.gov/pubmed/33355367
http://dx.doi.org/10.3892/mmr.2020.11788

Ejemplares similares